Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT07494812
- Status
- Recruiting
Conditions
- NPH (Normal Pressure Hydrocephalus)
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Intellidrop Automated CSF Drainage System — DEVICEParticipants will undergo lumbar drainage using the Intellidrop automated cerebrospinal fluid drainage system that monitors intracranial or spinal pressure and manages external drainage of cerebrospinal fluid and other body fluids to a user selected pressure target or volume target. Its closed loop, gravity-based drainage ensures natural flow, while offering position-agnostic precision control to achieve an hourly target volume. It connects to the distal end of the lumbar catheter outside the body and replaces the drainage collection device and manual nursing effort.
- Intellidrop Automated CSF Drainage System — DEVICEParticipants will undergo lumbar drainage using the Intellidrop automated cerebrospinal fluid drainage system that provides continuous intracranial pressure monitoring and automated control of CSF removal. It is programmed to withdraw small frequent volumes of CSF within predefined safety limits reducing the need for manual stopcock adjustments and minimizing human error. It is designed to improve workflow efficiency, enhance patient mobility, and evaluate the device;s feasibility, performance and safety during the lumbar drain.
Study Details
The intellidrop device is an FDA-approved system that automates safe, small volume of cerebral spinal fluid drainage with continuous pressure monitoring, reducing nursing workload and human error while improving patient mobility and comfort
Key Dates
- Start date
- May 14, 2026
- Status verified
- May 2026
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: Experimental - Intellidrop Automated CSF Drainage SystemDevice
Primary Outcome Measure
Feasibility [ Time Frame: FIM scores will be obtained on a daily basis during month 3 - 5. ]
Central Contacts
- Padraig O'Suilleabhain, M.D.214-648-2943
- Maria Denbow, CCRP214-648-6719
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UT Southwestern Medical Center | Dallas | Texas | 75390 | Padraig O'Suilleabhain, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Dallas, TX
By research site